Friday, 4 April 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 4 April 2025
Ascott/IQVIA
Ascott/IQVIA
CEO pay packets just keep going up

It's been a year of belt-tightening across pharma with many companies downsizing their workforces and expenditure but for the CEOs driving those changes it's been good for the hip pocket.

Company unveils new CBD office
ICYMI: See who's moved to a swish new office plus the other most popular stories this week
TODAY Your Week in 5 Minutes
Pharma messaging Drs remember
New report reveals what sticks with HCPs after analysing 14,000 messages across 380 pharma brands
TODAY
49 submissions on PBAC's desk
Reimbursement committee has dropped the agenda for its July meeting - with 14 innovative drugs seeking their first PBS listing
3 April
Drugs quietly listed on the PBS
While the Albanese Government has been drip-feeding PBS listings ahead of the election, there were still some surprises this month
2 April New to the PBS
Lifeline arrives for world's top drug
With a patent cliff looming, results from a pivotal Phase 3 trial could see this cancer drug remain a blockbuster for much longer
2 April
TGA greenlights 17 new drug uses
Big drugs grow even bigger, scoring multiple new uses while others have beaten their rivals to new indications
1 April
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (17)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (6)

Executive Roles (1)

Other (19)

NZ promises 30-day fast lane
The New Zealand government has passed legislation that will streamline approval for some meds to less than a month
TODAY
Cost of PBS medicines laid bare
New analysis shines a light on how much the PBS helps keep the prices Australians pay for medicine low
TODAY
Trump lets pharma off the hook
After much industry angst over the impact of US tariffs on pharma, the US President offers an exemption... for now
3 April
Warehouse opens for 1M PBS meds
State-of-the-art-warehouse facility opens in the Treasurer's electorate in Queensland, offering a perfect election photo op
3 April
Top drugs chase bigger markets
Change to listing submissions for big name drugs seeking new indications and expanded populations
3 April
Discontinued vax for dementia?
Australian experts weigh in on a new Standford University study that could have 'profound' implications
3 April
New brand targets US expansion
Aussie pharma announces compounded version of ED nasal spray as the original product goes through FDA approval
2 April
High-flyers face off again
Familiar names in pharma legal counsel nominated for prestigious awards... and it's not their first time. See who's in the running
2 April
Aussie boss nails $1.6B Novo deal
Brokers lucrative agreement with Danish pharma giant for a pre-clinical drug targeting a novel obesity pathway
2 April
Biggest ever pharma tax dodge?
This company sold US$20 billion worth of drugs to American patients in a year yet paid zero US tax
1 April
New player joins PBC market
Company celebrates TGA approval of innovative product as it awaits the PBAC's decision from the March meeting
1 April
Fast listing for GSK's Aussie drug
Bone marrow cancer drug discovered in Melbourne took just four months to win subsidy after TGA approval
1 April
$96.3M PBS drug wins expansion
First targeted treatment option to be reimbursed for Australians living with a rare, unpredictable and debilitating autoimmune disease
1 April
Novo pioneers Aussie pharma first
Establishes council to improve the health of Aboriginal and Torres Strait Islander people living with diabetes and obesity
31 March
PiF advertise
PiF advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.